# Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth

> **NCT02897076** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 3250 (actual)

## Conditions studied

- Neonatal Complications

## Interventions

- **DRUG:** betamethasone 24 mg
- **DRUG:** 12mg betamethasone +placebo

## Key facts

- **NCT ID:** NCT02897076
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2020-01-05
- **Final completion:** 2020-01-05
- **Target enrollment:** 3250 (ACTUAL)
- **Last updated:** 2023-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02897076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02897076, "Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02897076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*